| Title : Memogain is a galantamine pro-drug having dramatically reduced adverse effects and enhanced efficacy - Maelicke_2010_J.Mol.Neurosci_40_135 |
| Author(s) : Maelicke A , Hoeffle-Maas A , Ludwig J , Maus A , Samochocki M , Jordis U , Koepke AK |
| Ref : Journal of Molecular Neuroscience , 40 :135 , 2010 |
| Abstract : Maelicke_2010_J.Mol.Neurosci_40_135 |
| ESTHER : Maelicke_2010_J.Mol.Neurosci_40_135 |
| PubMedSearch : Maelicke_2010_J.Mol.Neurosci_40_135 |
| PubMedID: 19669943 |